This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
ECTORS, the European Cell Therapy and Organ Regeneration Section of ESOT, would like to announce a call for nominations for two new Board members. ESOT/ECTORS members active in the field of regenerative medicine or cell therapy are eligible to submit their applications for the positions. The Board reserves the right to shortlist candidates on the
Extended deadline for the #ITSmeeting abstract submission: 19 January 2022 [at 23:59 CET]
This educational webinar will discuss the efficacy of current COVID-19 vaccine strategies for transplanted patients. The first talk will focus on the experience with heterologous vaccinations and the pro´s and con´s for vector vaccines in transplant patients. The second talk summarises previous studies on second and third booster (homogenous and heterologous) vaccinations – and gives
We would like to announce a call for nominations for two new Board members. ESOT/ECTORS members active in the field of regenerative medicine or cell therapy are eligible to submit their application for the positions. The Board reserves the right to shortlist candidates on the basis of their specialty. If you wish to apply, please
REGISTER TODAY – CLICK HERE Registration to 2nd ECTORS Meeting is complimentary, but only registered participants will have access. The Programme is available here
The abstract submission deadline for #ESOTcongress has been EXTENDED until Thursday 25th February at 23:59 CET.
Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader
ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.
We are pleased to announce that our TLJ 2.0 report has been published and is available to read now. Providing a comprehensive summary of TLJ 2.0, this report covers all the highlights from the event, including the key discussion points and outcomes from some of the World’s leading transplant experts. Read the TLJ20Report for the